Difference between revisions of "Resource:E273cee3-0907-4841-9126-9cee08518338"
From The Embassy of Good Science
Marc.VanHoof (talk | contribs) |
|||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
|Resource Type=Cases | |Resource Type=Cases | ||
|Title=Up, Up, and Away: Clinical Trials Go International | |Title=Up, Up, and Away: Clinical Trials Go International | ||
| − | |Is About=This is a | + | |Is About=This is a short interview with a research who describes some of the ethical issues that arise from running international clinical trials. The researcher gives the example of the fictional US based company Rx who wants to run a trial in Russia for a certain medication. One reason for such a company to 'outsource' a clinical trial is lower costs in other countries. Questions asked in the case include 'what is the quality of the informed consent?' and 'can you promise participants to receive a certain drug for the study period, but not afterwards?' |
| − | + | |Important Because=As described in the case: "Clinical trials are one of the most expensive steps in pharmaceutical and device development for biomedical companies. Each phase of the trial can cost up to twenty million dollars to run."<ref>https://www.scu.edu/ethics/focus-areas/bioethics/resources/up-up-and-away-clinical-trials-go-international/</ref> However, clinical trials are an important step to ensure the efficiency, safety and dosage of a drug. | |
| − | + | <references /> | |
| − | + | |Important For=Researchers; PhD students; Research integrity trainers | |
| − | |||
| − | |Important For=Researchers | ||
}} | }} | ||
{{Link | {{Link | ||
|Has Link=https://www.scu.edu/ethics/focus-areas/bioethics/resources/up-up-and-away-clinical-trials-go-international/ | |Has Link=https://www.scu.edu/ethics/focus-areas/bioethics/resources/up-up-and-away-clinical-trials-go-international/ | ||
}} | }} | ||
| − | {{Related To}} | + | {{Related To |
| + | |Related To Resource=Resource:08657792-f22e-486e-a034-c78fb9a2f39f;Resource:4c1137a3-8b5e-411e-bc98-18ae6818d7b8 | ||
| + | |Related To Theme=Theme:9ac8c1db-f98b-41ee-858d-a8c93a647108 | ||
| + | }} | ||
{{Tags | {{Tags | ||
|Has Virtue And Value=Accountability | |Has Virtue And Value=Accountability | ||
Latest revision as of 14:03, 14 October 2020
ResourcesCases
Up, Up, and Away: Clinical Trials Go International
What is this about?
This is a short interview with a research who describes some of the ethical issues that arise from running international clinical trials. The researcher gives the example of the fictional US based company Rx who wants to run a trial in Russia for a certain medication. One reason for such a company to 'outsource' a clinical trial is lower costs in other countries. Questions asked in the case include 'what is the quality of the informed consent?' and 'can you promise participants to receive a certain drug for the study period, but not afterwards?'
Why is this important?
As described in the case: "Clinical trials are one of the most expensive steps in pharmaceutical and device development for biomedical companies. Each phase of the trial can cost up to twenty million dollars to run."[1] However, clinical trials are an important step to ensure the efficiency, safety and dosage of a drug.
